<SEC-DOCUMENT>0001127602-18-026014.txt : 20180822
<SEC-HEADER>0001127602-18-026014.hdr.sgml : 20180822
<ACCEPTANCE-DATETIME>20180822165802
ACCESSION NUMBER:		0001127602-18-026014
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20180820
FILED AS OF DATE:		20180822
DATE AS OF CHANGE:		20180822

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Voytas Daniel F
		CENTRAL INDEX KEY:			0001712191

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38161
		FILM NUMBER:		181032961

	MAIL ADDRESS:	
		STREET 1:		600 COUNTY ROAD D WEST
		STREET 2:		SUITE 8
		CITY:			NEW BRIGHTON
		STATE:			MN
		ZIP:			55112

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Calyxt, Inc.
		CENTRAL INDEX KEY:			0001705843
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				271967997
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2800 MOUNT RIDGE ROAD
		CITY:			ROSEVILLE
		STATE:			MN
		ZIP:			55113
		BUSINESS PHONE:		(651) 683-2807

	MAIL ADDRESS:	
		STREET 1:		2800 MOUNT RIDGE ROAD
		CITY:			ROSEVILLE
		STATE:			MN
		ZIP:			55113
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2018-08-20</periodOfReport>

    <issuer>
        <issuerCik>0001705843</issuerCik>
        <issuerName>Calyxt, Inc.</issuerName>
        <issuerTradingSymbol>CLXT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001712191</rptOwnerCik>
            <rptOwnerName>Voytas Daniel F</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>2800 MOUNT RIDGE ROAD</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>ROSEVILLE</rptOwnerCity>
            <rptOwnerState>MN</rptOwnerState>
            <rptOwnerZipCode>55113</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isOfficer>1</isOfficer>
            <officerTitle>Chief Science Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2018-08-20</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>M</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>4666</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>3.59</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>97648</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2018-08-20</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F2"/>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>4666</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>17.31</value>
                    <footnoteId id="F3"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>92982</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>3.59</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2018-08-20</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>M</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>4666</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F4"/>
            </exerciseDate>
            <expirationDate>
                <value>2026-04-07</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>4666</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>217004</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.</footnote>
        <footnote id="F2">The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.</footnote>
        <footnote id="F3">The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $17.03 to $17.67, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.</footnote>
        <footnote id="F4">The Stock Option was granted on April 7, 2016 and vests 20% on the grant date and 10% on the first anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter).</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ David M. Vander Haar, attorney-in-fact for Dr. Voytas</signatureName>
        <signatureDate>2018-08-22</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>doc1.htm
<DESCRIPTION>POWER OF ATTORNEY
<TEXT>
<HTML><HEAD><TITLE>Daniel F Voytas  POA</TITLE></HEAD><BODY style="font-family:Bookman Old Style"><TABLE CELLSPACING="0" BORDER="0" WIDTH="588"><TR><TD VALIGN="TOP" COLSPAN="3"><H1 ALIGN="RIGHT" STYLE="font-size:140%">EXHIBIT 24</H1></TD></TR><TR height="10"><td><div /></td></TR><TR height="10"><td><div /></td></TR><TR><TD VALIGN="TOP" COLSPAN="3"><H1 ALIGN="center" STYLE="font-size:140%">Calyxt, Inc.</H1><H2 ALIGN="CENTER" STYLE="font-size:120%">Power of Attorney<BR />
							for Executing Forms 3, 4 and 5</H2></TD></TR><TR height="10"><td><div /></td></TR><TR><TD VALIGN="TOP" COLSPAN="3"><dd />Know
								all men by these presents, that the undersigned, director or officer, or
								both, of Calyxt, Inc., hereby constitutes
								and appoints each of David M. Vander Haar,
								signing singly, the undersigned's true and lawful attorney-in-fact to:
						</TD></TR><TR height="10"><td><div /></td></TR><TR><TD WIDTH="16%" VALIGN="TOP" ALIGN="center">
								(1)
						</TD><TD WIDTH="84%" VALIGN="TOP" COLSPAN="2">
								execute for and on behalf of the undersigned, in the undersigned's capacity
								as an officer and/or director of Calyxt, Inc. (the "Company"),
								Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange
								Act of 1934 and the rules thereunder;
						</TD></TR><TR height="10"><td><div /></td></TR><TR><TD WIDTH="16%" VALIGN="TOP" ALIGN="center">
								(2)
						</TD><TD WIDTH="84%" VALIGN="TOP" COLSPAN="2">
							do and perform any and all acts for and on behalf of the undersigned which may
							be necessary or desirable to complete and execute any such Form 3, 4 or 5 and
							timely file such form with the United States Securities and Exchange Commission
							and any stock exchange or similar authority; and
						</TD></TR><TR height="10"><td><div /></td></TR><TR><TD WIDTH="16%" VALIGN="TOP" ALIGN="center">
								(3)
						</TD><TD WIDTH="84%" VALIGN="TOP" COLSPAN="2">
							take any other action of any type whatsoever in connection with the foregoing
							which, in the opinion of such attorney-in-fact, may be of benefit to, in the
							best interest of, or legally required by, the undersigned, it being understood
							that the documents executed by such attorney-in-fact on behalf of the undersigned
							pursuant to this Power of Attorney shall be in such form and shall contain such
							terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's
							discretion.
						</TD></TR><TR height="10"><td><div /></td></TR><TR><TD VALIGN="TOP" COLSPAN="3"><dd />The
								undersigned hereby grants to each such attorney-in-fact full power and authority
								to do and perform any and every act and thing whatsoever requisite, necessary,
								or proper to be done in the exercise of any of the rights and powers herein
								granted, as fully to all intents and purposes as the undersigned might or could
								do if personally present, with full power of substitution or revocation, hereby
								ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's
								substitute or substitutes, shall lawfully do or cause to be done by virtue of
								this power of attorney and the rights and powers herein granted. The undersigned
								acknowledges that the foregoing attorneys-in-fact, in serving in such capacity
								at the request of the undersigned, are not assuming, nor is the Company assuming,
								any of the undersigned's responsibilities to comply with Section 16 of the Securities
								Exchange Act of 1934.
						</TD></TR><TR height="10"><td><div /></td></TR><TR><TD VALIGN="TOP" COLSPAN="3"><dd />This
								Power of Attorney shall remain in full force and effect until the undersigned
								is no longer required to file Forms 3, 4 and 5 with respect to the
								undersigned's holdings of and transactions in securities of Calyxt, Inc.
								unless earlier revoked by the undersigned in a signed writing
								delivered to the foregoing attorneys-in-fact.
						</TD></TR><TR height="10"><td><div /></td></TR><TR><TD VALIGN="TOP" COLSPAN="3"><dd />IN
								WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of this 12<sup>th</sup>
								day of March, 2018</TD></TR><TR height="10"><td><div /></td></TR></TABLE><table border="0" width="100%" cellpadding="1" WIDTH="588"><tr><td rowspan="2" width="64%" /><td style="border-bottom: solid black 1px" width="36%">
						/s/ Daniel F Voytas</td></tr><tr><td>Daniel F Voytas</td></tr></table></BODY></HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
